A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus

Norbert Varga, Ieva Sutkeviciute, Renato Ribeiro-Viana, Angela Berzi, Rasika Ramdasi, Anna Daghetti, Gerolamo Vettoretti, Ali Amara, Mario Clerici, Javier Rojo, Franck Fieschi, Anna Bernardi

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

DC-SIGN is a C-type lectin receptor on antigen presenting cells (dendritic cells) which has an important role in some viral infection, notably by HIV and Dengue virus (DV). Multivalent presentation of carbohydrates on dendrimeric scaffolds has been shown to inhibit DC-SIGN binding to HIV envelope glycoprotein gp120, thus blocking viral entry. This approach has interesting potential applications for infection prophylaxis. In an effort to develop high affinity inhibitors of DC-SIGN mediated viral entry, we have synthesized a group of glycodendrimers of different valency that bear different carbohydrates or glycomimetic DC-SIGN ligands and have studied their DC-SIGN binding activity and antiviral properties both in an HIV and a Dengue infection model. Surface Plasmon Resonance (SPR) competition studies have demonstrated that the materials obtained bind efficiently to DC-SIGN with IC50s in the μm range, which depend on the nature of the ligand and on the valency of the scaffold. In particular, a hexavalent presentation of the DC-SIGN selective antagonist 4 displayed high potency, as well as improved accessibility and chemical stability relative to previously reported dendrimers. At low μm concentration the material was shown to block both DC-SIGN mediated uptake of DV by Raji cells and HIV trans-infection of T cells.

Original languageEnglish
Pages (from-to)4175-4184
Number of pages10
JournalBiomaterials
Volume35
Issue number13
DOIs
Publication statusPublished - Apr 2014

Fingerprint

Dengue Virus
Carbohydrates
Viruses
Scaffolds
HIV-1
Ligands
Glycoproteins
T-cells
Dendrimers
Chemical stability
Surface plasmon resonance
HIV Envelope Protein gp120
HIV
C-Type Lectins
Surface Plasmon Resonance
Dengue
DC-specific ICAM-3 grabbing nonintegrin
Antigen-Presenting Cells
Virus Diseases
Infection

Keywords

  • DC-SIGN
  • Dengue
  • Glycodendrimers
  • Glycomimetics
  • HIV
  • Nanotechnology

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics
  • Medicine(all)

Cite this

Varga, N., Sutkeviciute, I., Ribeiro-Viana, R., Berzi, A., Ramdasi, R., Daghetti, A., ... Bernardi, A. (2014). A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus. Biomaterials, 35(13), 4175-4184. https://doi.org/10.1016/j.biomaterials.2014.01.014

A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus. / Varga, Norbert; Sutkeviciute, Ieva; Ribeiro-Viana, Renato; Berzi, Angela; Ramdasi, Rasika; Daghetti, Anna; Vettoretti, Gerolamo; Amara, Ali; Clerici, Mario; Rojo, Javier; Fieschi, Franck; Bernardi, Anna.

In: Biomaterials, Vol. 35, No. 13, 04.2014, p. 4175-4184.

Research output: Contribution to journalArticle

Varga, N, Sutkeviciute, I, Ribeiro-Viana, R, Berzi, A, Ramdasi, R, Daghetti, A, Vettoretti, G, Amara, A, Clerici, M, Rojo, J, Fieschi, F & Bernardi, A 2014, 'A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus', Biomaterials, vol. 35, no. 13, pp. 4175-4184. https://doi.org/10.1016/j.biomaterials.2014.01.014
Varga N, Sutkeviciute I, Ribeiro-Viana R, Berzi A, Ramdasi R, Daghetti A et al. A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus. Biomaterials. 2014 Apr;35(13):4175-4184. https://doi.org/10.1016/j.biomaterials.2014.01.014
Varga, Norbert ; Sutkeviciute, Ieva ; Ribeiro-Viana, Renato ; Berzi, Angela ; Ramdasi, Rasika ; Daghetti, Anna ; Vettoretti, Gerolamo ; Amara, Ali ; Clerici, Mario ; Rojo, Javier ; Fieschi, Franck ; Bernardi, Anna. / A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus. In: Biomaterials. 2014 ; Vol. 35, No. 13. pp. 4175-4184.
@article{e7c017385c1d476b82bcbeed594beb2b,
title = "A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus",
abstract = "DC-SIGN is a C-type lectin receptor on antigen presenting cells (dendritic cells) which has an important role in some viral infection, notably by HIV and Dengue virus (DV). Multivalent presentation of carbohydrates on dendrimeric scaffolds has been shown to inhibit DC-SIGN binding to HIV envelope glycoprotein gp120, thus blocking viral entry. This approach has interesting potential applications for infection prophylaxis. In an effort to develop high affinity inhibitors of DC-SIGN mediated viral entry, we have synthesized a group of glycodendrimers of different valency that bear different carbohydrates or glycomimetic DC-SIGN ligands and have studied their DC-SIGN binding activity and antiviral properties both in an HIV and a Dengue infection model. Surface Plasmon Resonance (SPR) competition studies have demonstrated that the materials obtained bind efficiently to DC-SIGN with IC50s in the μm range, which depend on the nature of the ligand and on the valency of the scaffold. In particular, a hexavalent presentation of the DC-SIGN selective antagonist 4 displayed high potency, as well as improved accessibility and chemical stability relative to previously reported dendrimers. At low μm concentration the material was shown to block both DC-SIGN mediated uptake of DV by Raji cells and HIV trans-infection of T cells.",
keywords = "DC-SIGN, Dengue, Glycodendrimers, Glycomimetics, HIV, Nanotechnology",
author = "Norbert Varga and Ieva Sutkeviciute and Renato Ribeiro-Viana and Angela Berzi and Rasika Ramdasi and Anna Daghetti and Gerolamo Vettoretti and Ali Amara and Mario Clerici and Javier Rojo and Franck Fieschi and Anna Bernardi",
year = "2014",
month = "4",
doi = "10.1016/j.biomaterials.2014.01.014",
language = "English",
volume = "35",
pages = "4175--4184",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "13",

}

TY - JOUR

T1 - A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus

AU - Varga, Norbert

AU - Sutkeviciute, Ieva

AU - Ribeiro-Viana, Renato

AU - Berzi, Angela

AU - Ramdasi, Rasika

AU - Daghetti, Anna

AU - Vettoretti, Gerolamo

AU - Amara, Ali

AU - Clerici, Mario

AU - Rojo, Javier

AU - Fieschi, Franck

AU - Bernardi, Anna

PY - 2014/4

Y1 - 2014/4

N2 - DC-SIGN is a C-type lectin receptor on antigen presenting cells (dendritic cells) which has an important role in some viral infection, notably by HIV and Dengue virus (DV). Multivalent presentation of carbohydrates on dendrimeric scaffolds has been shown to inhibit DC-SIGN binding to HIV envelope glycoprotein gp120, thus blocking viral entry. This approach has interesting potential applications for infection prophylaxis. In an effort to develop high affinity inhibitors of DC-SIGN mediated viral entry, we have synthesized a group of glycodendrimers of different valency that bear different carbohydrates or glycomimetic DC-SIGN ligands and have studied their DC-SIGN binding activity and antiviral properties both in an HIV and a Dengue infection model. Surface Plasmon Resonance (SPR) competition studies have demonstrated that the materials obtained bind efficiently to DC-SIGN with IC50s in the μm range, which depend on the nature of the ligand and on the valency of the scaffold. In particular, a hexavalent presentation of the DC-SIGN selective antagonist 4 displayed high potency, as well as improved accessibility and chemical stability relative to previously reported dendrimers. At low μm concentration the material was shown to block both DC-SIGN mediated uptake of DV by Raji cells and HIV trans-infection of T cells.

AB - DC-SIGN is a C-type lectin receptor on antigen presenting cells (dendritic cells) which has an important role in some viral infection, notably by HIV and Dengue virus (DV). Multivalent presentation of carbohydrates on dendrimeric scaffolds has been shown to inhibit DC-SIGN binding to HIV envelope glycoprotein gp120, thus blocking viral entry. This approach has interesting potential applications for infection prophylaxis. In an effort to develop high affinity inhibitors of DC-SIGN mediated viral entry, we have synthesized a group of glycodendrimers of different valency that bear different carbohydrates or glycomimetic DC-SIGN ligands and have studied their DC-SIGN binding activity and antiviral properties both in an HIV and a Dengue infection model. Surface Plasmon Resonance (SPR) competition studies have demonstrated that the materials obtained bind efficiently to DC-SIGN with IC50s in the μm range, which depend on the nature of the ligand and on the valency of the scaffold. In particular, a hexavalent presentation of the DC-SIGN selective antagonist 4 displayed high potency, as well as improved accessibility and chemical stability relative to previously reported dendrimers. At low μm concentration the material was shown to block both DC-SIGN mediated uptake of DV by Raji cells and HIV trans-infection of T cells.

KW - DC-SIGN

KW - Dengue

KW - Glycodendrimers

KW - Glycomimetics

KW - HIV

KW - Nanotechnology

UR - http://www.scopus.com/inward/record.url?scp=84896726186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896726186&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2014.01.014

DO - 10.1016/j.biomaterials.2014.01.014

M3 - Article

C2 - 24508075

AN - SCOPUS:84896726186

VL - 35

SP - 4175

EP - 4184

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 13

ER -